secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0000950170-22-026875
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Corbus shareholders approve reverse stock split at ratio up to 1:40
-------------------------------------------------------------------

- Shareholders approved amendment to authorize reverse split from 1:4 to 1:40, board to set exact ratio.
- Adjournment proposal also approved; both items passed at special meeting on Dec 20, 2022.
- Record date for voting was Nov 7, 2022, with 125,280,881 common shares outstanding.
- Final vote on reverse split: 25.79 trillion for, 5.06 trillion against, 0.47 trillion abstentions.
- Reverse split intended to meet Nasdaq listing requirements and raise per-share price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017022026875/0000950170-22-026875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017022026875/crbp-20221220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer